Double-blind fluoxetine trial in comorbid MDD–CUD youth and young adults - Cornelius, Jack R.; Bukstein, Oscar G.; Douaihy, Antoine B.; Clark, Duncan B.; Chung, Tammy A.; Daley, Dennis C.; Wood, D. Scott; Brown, Sandra J. (Drug and alcohol dependence, 2010)
Keywords: Addictive behaviors; Adolescent; Adult; Adult and adolescent clinical studies; Antidepressive Agents, Second-Generation - adverse effects; Antidepressive Agents, Second-Generation - therapeutic use; Biological and medical sciences; Cannabis; Cannabis use disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depression; Depressive Disorder, Major - drug therapy; Depressive Disorder, Major - therapy; Double-Blind Method; Drug addiction; Efficacy; Female; Fluoxetine; Fluoxetine - adverse effects; Fluoxetine - therapeutic use; Humans; Major depressive disorder; Male; Marijuana Abuse - drug therapy; Medical sciences; Mood disorders; Motivation enhancement therapy; Neuropharmacology; Pharmacology. Drug treatments; Placebos; Psychiatry; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease); Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychopharmacology; Treatment Outcome; Young Adult; Young people; Motivation enhancement therapy; Cannabis use disorder; Fluoxetine; Major depressive disorder; Cognitive behavioral therapy; Psychotropic; Cannabidaceae; Reuptake inhibitor; Selective serotonin reuptake inhibitor; Cannabis; Motivation; Dicotyledones; Angiospermae; Antidepressant agent; Drug of abuse; Behavior therapy; Human; Mood disorder; Drug addiction; Cognitive therapy; Serotonin; Use; Depression; Concomitant disease; Treatment; Addiction; Adolescent; Young adult; Neurotransmitter; Double blind study; Spermatophyta; Severe; Recreational drug